{"denoms":[{"counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"}],"units":"Participants"}],"groups":[{"description":"Induction therapy + single myeloablative consolidation","id":"OG000","title":"Single HST (CEM)"},{"description":"Induction therapy + tandem myeloablative consolidation","id":"OG001","title":"Tandem HST (CEM), Randomly Assigned"},{"description":"Patients that either failed during Induction therapy or refused randomization","id":"OG002","title":"Not Assigned"}],"populationDescription":"Data were not collected to assess this study aim.","reportingStatus":"POSTED","timeFrame":"Up to 6 months (end of therapy)","title":"Presence and Function of T Cells Capable of Recognizing Neuroblastoma","type":"SECONDARY"}